Kensey Nash (KNSY) surges 32% to $38.33, nearing the $38.50/share that Royal DSM (RDSMY.PK) is paying for the medical-device company.
|May 3, 2012, 10:50 AM
May 3, 2012, 2:28 AM
Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR)